LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.88 | 17.25 | 702 | 534 | 1.3136 | 1.1132 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.88 | 17.25 | 1086 | 534 | 2.0321 | 1.3078 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.85 | 17.25 | 705 | 655 | 1.0754 | 1.0279 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.85 | 17.25 | 15 | 655 | 0.0229 | -0.0263 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.85 | 17.25 | 1122 | 655 | 1.7115 | 1.2156 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.82 | 17.25 | 744 | 800 | 0.9294 | 0.9737 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.82 | 17.25 | 22 | 800 | 0.0275 | 0.0449 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.82 | 17.25 | 1132 | 800 | 1.4141 | 1.1292 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.79 | 17.25 | 744 | 1001 | 0.7428 | 0.9010 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.79 | 17.25 | 99 | 1001 | 0.0988 | 0.3474 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.79 | 17.25 | 1181 | 1001 | 1.1791 | 1.0570 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.76 | 17.25 | 774 | 1193 | 0.6485 | 0.8632 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.76 | 17.25 | 126 | 1193 | 0.1056 | 0.3845 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.76 | 17.25 | 1237 | 1193 | 1.0364 | 1.0117 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.73 | 17.25 | 841 | 1290 | 0.6518 | 0.8671 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.73 | 17.25 | 116 | 1290 | 0.0899 | 0.3582 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.73 | 17.25 | 1264 | 1290 | 0.9797 | 0.9934 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.70 | 17.25 | 900 | 1466 | 0.6136 | 0.8533 | MN20160310_N02 | D16 |